Vida Ventures Advisors 13F annual report

Vida Ventures Advisors is an investment fund managing more than $76.6 billion ran by Jean-philippe Kouakou-zebouah. There are currently 7 companies in Kouakou-zebouah’s portfolio. The largest investments include Centessa Pharmaceuticals Plc and Dyne Therapeutics, together worth $58.9 billion.

$76.6 billion Assets Under Management (AUM)

As of 29th December 2023, Vida Ventures Advisors’s top holding is 3,931,818 shares of Centessa Pharmaceuticals Plc currently worth over $31.3 billion and making up 37.3% of the portfolio value.In addition, the fund holds 2,074,787 shares of Dyne Therapeutics worth $27.6 billion, whose value grew 75.2% in the past six months. The third-largest holding is Lianbio worth $10.2 billion and the next is Allogene Therapeutics Inc worth $5.77 billion, with 1,798,163 shares owned.

Currently, Vida Ventures Advisors's portfolio is worth at least $76.6 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Vida Ventures Advisors

The Vida Ventures Advisors office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Jean-philippe Kouakou-zebouah serves as the Chief Financial Officer at Vida Ventures Advisors.